<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03172065</url>
  </required_header>
  <id_info>
    <org_study_id>IDGL</org_study_id>
    <nct_id>NCT03172065</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine and Laparoscopic Surgery</brief_title>
  <official_title>Intrathecal Dexmedetomidine Versus I.V Ketorolac in Prevention of Shoulder Tip Pain in Gynecological Laparoscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Conventionally General anaesthesia remains the choice for the majority of open abdominal
      surgical procedures, and regional anaesthesia is preferred only for patients who are at high
      risk under general anaesthesia . The main reason for selecting spinal anaesthesia as the
      first choice for laparoscopic cases was its advantages over general anaesthesia which include
      uniform total muscle relaxation, a conscious patient, economical, relatively uneventful
      recovery, pain free early postoperative period and the protection from potential
      complications of general anaesthesia. The main debatable point, however, seems to be the
      status of respiratory parameters among the two modes of anaesthesia during laparoscopic
      surgery. In this context it can be stated that spontaneous physiological respiration during
      spinal anaesthesia would always be better than an assisted respiration as in general
      anaesthesia.

      The pneumo-peritoneum induced rise in intra-abdominal pressure including pressure on the
      diaphragm and carbon dioxide induced peritoneal irritation are the factors to be considered
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence shoulder tip pain</measure>
    <time_frame>8 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>intraoperative haemodynamic stability, et co2, sao2.</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia Complication</condition>
  <arm_group>
    <arm_group_label>ketorolac group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>will receive 3 ml (15 mg) hyperbaric Bupivacaine + 0.5 ml saline + 60mg ketorolac I.V infusion 30 minutes before anaesthesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>will receive 3 ml (15 mg) hyperbaric Bupivacaine + 0.5 ml dexmedetomidine (0.5 mic)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyperbaric Bupivacaine</intervention_name>
    <description>anaesthetic drug</description>
    <arm_group_label>ketorolac group</arm_group_label>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketorolac</intervention_name>
    <description>pain killer, anaesthesia adjuvants</description>
    <arm_group_label>ketorolac group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>anaesthetic adjuvants and pain killer medication.</description>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective gynaecological laparoscopic surgery

          -  Age 20-45 yrs

          -  Suspected surgery time 30 minutes

          -  Inflation pressure &lt;13 Cm H20

        Exclusion Criteria:

          -  Contraindications to regional block (infection at the needle insertion site)

          -  Altered conscious level.

          -  Pregnancy

          -  Body mass index &gt;35

          -  Height &lt;155 cm

          -  Patients who have difficulty understanding the study protocol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rasha Hamed, MD</last_name>
    <phone>+20882414616</phone>
    <email>rashaahmed11@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohammed Ali, MD</last_name>
    <email>MOHAMMEDELKOSY@YAHOO.COM</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mohammed Ali Ahmed, MD</last_name>
      <email>amira_salem2015@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2017</study_first_submitted>
  <study_first_submitted_qc>May 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2017</study_first_posted>
  <last_update_submitted>May 28, 2017</last_update_submitted>
  <last_update_submitted_qc>May 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Rasha Hamed</investigator_full_name>
    <investigator_title>Lecturer of anesthesia</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

